208 related articles for article (PubMed ID: 15658847)
1. Generation of "neoheparin" from E. coli K5 capsular polysaccharide.
Lindahl U; Li JP; Kusche-Gullberg M; Salmivirta M; Alaranta S; Veromaa T; Emeis J; Roberts I; Taylor C; Oreste P; Zoppetti G; Naggi A; Torri G; Casu B
J Med Chem; 2005 Jan; 48(2):349-52. PubMed ID: 15658847
[TBL] [Abstract][Full Text] [Related]
2. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide.
Razi N; Feyzi E; Björk I; Naggi A; Casu B; Lindahl U
Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):465-72. PubMed ID: 7626010
[TBL] [Abstract][Full Text] [Related]
4. Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.
Naggi A; Torri G; Casu B; Oreste P; Zoppetti G; Li JP; Lindahl U
Semin Thromb Hemost; 2001 Oct; 27(5):437-43. PubMed ID: 11668413
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of thrombin-inhibiting heparin mimetics without side effects.
Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
Nature; 1999 Apr; 398(6726):417-22. PubMed ID: 10201371
[TBL] [Abstract][Full Text] [Related]
6. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
[TBL] [Abstract][Full Text] [Related]
8. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
9. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
Petitou M; van Boeckel CA
Angew Chem Int Ed Engl; 2004 Jun; 43(24):3118-33. PubMed ID: 15199558
[TBL] [Abstract][Full Text] [Related]
10. Insights into the induced fit mechanism in antithrombin-heparin interaction using molecular dynamics simulations.
Verli H; Guimarães JA
J Mol Graph Model; 2005 Dec; 24(3):203-12. PubMed ID: 16146701
[TBL] [Abstract][Full Text] [Related]
11. Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5.
Casu B; Grazioli G; Razi N; Guerrini M; Naggi A; Torri G; Oreste P; Tursi F; Zoppetti G; Lindahl U
Carbohydr Res; 1994 Oct; 263(2):271-84. PubMed ID: 7805054
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.
Kusche M; Hannesson HH; Lindahl U
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):151-8. PubMed ID: 1902083
[TBL] [Abstract][Full Text] [Related]
13. Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.
Cipriani TR; Gracher AH; de Souza LM; Fonseca RJ; Belmiro CL; Gorin PA; Sassaki GL; Iacomini M
Thromb Haemost; 2009 May; 101(5):860-6. PubMed ID: 19404539
[TBL] [Abstract][Full Text] [Related]
14. [From heparin to synthetic antithrombotic oligosaccharides].
Petitou M
Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
[TBL] [Abstract][Full Text] [Related]
15. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
[TBL] [Abstract][Full Text] [Related]
16. Structural relation of the antigenic polysaccharides of Escherichia coli O40, Shigella dysenteriae type 9, and E. coli K47.
Zhao G; Perepelov AV; Senchenkova SN; Shashkov AS; Feng L; Li X; Knirel YA; Wang L
Carbohydr Res; 2007 Jul; 342(9):1275-9. PubMed ID: 17395169
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the enzymatic cleavage (beta elimination) of the capsular K5 polysaccharide of Escherichia coli by the K5-specific coliphage: reexamination.
Hänfling P; Shashkov AS; Jann B; Jann K
J Bacteriol; 1996 Aug; 178(15):4747-50. PubMed ID: 8755913
[TBL] [Abstract][Full Text] [Related]
18. Investigating the molecular basis for the virulence of Escherichia coli K5 by nuclear magnetic resonance analysis of the capsule polysaccharide.
Blundell CD; Roberts IS; Sheehan JK; Almond A
J Mol Microbiol Biotechnol; 2009; 17(2):71-82. PubMed ID: 19401610
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant and antithrombotic activities of a chemically sulfated galactoglucomannan obtained from the lichen Cladonia ibitipocae.
Martinichen-Herrero JC; Carbonero ER; Sassaki GL; Gorin PA; Iacomini M
Int J Biol Macromol; 2005 Mar; 35(1-2):97-102. PubMed ID: 15769521
[TBL] [Abstract][Full Text] [Related]
20. Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
Urbinati C; Bugatti A; Oreste P; Zoppetti G; Waltenberger J; Mitola S; Ribatti D; Presta M; Rusnati M
FEBS Lett; 2004 Jun; 568(1-3):171-7. PubMed ID: 15196942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
